Novel TRAF1-ALK fusion identified by deep RNA sequencing of anaplastic large cell lymphoma

Genes Chromosomes and Cancer

Volumn 52, Issue 11, 2013, Pages 1097-1102

  Feldman, Andrew L ^a   Vasmatzis, George ^a   Asmann, Yan W ^b   Davila, Jaime ^a   Middha, Sumit ^a   Eckloff, Bruce W ^a   Johnson, Sarah H ^a   Porcher, Julie C ^a   Ansell, Stephen M ^a   Caride, Ariel ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; MESSENGER RNA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1;

ADULT; ALK GENE; ARTICLE; CANCER TISSUE; CASE REPORT; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; CYTOPLASM; EXON; GENE; GENE FUSION; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LARGE CELL LYMPHOMA; MALE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA SEQUENCE; TRAF1 GENE; WESTERN BLOTTING;

EID: 84884700620     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22104     Document Type: Article

References (18)

1. Asmann YW, Hossain A, Necela BM, Middha S, Kalari KR, Sun Z, Chai HS, Williamson DW, Radisky D, Schroth GP, Kocher JP, Perez EA, Thompson EA. 2011. A novel bioinformatics pipeline for identification and characterization of fusion transcripts in breast cancer and normal cell lines. Nucleic Acids Res 39:e100.
2. Benharroch D, Meguerian-Bedoyan Z, Lamant L, Amin C, Brugieres L, Terrier-Lacombe MJ, Haralambieva E, Pulford K, Pileri S, Morris SW, Mason DY, Delsol G. 1998. ALK-positive lymphoma: A single disease with a broad spectrum of morphology. Blood 91:2076-2084.
3. Benner MF, Jansen PM, Meijer CJ, Willemze R. 2009. Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders. Br J Dermatol 161:121-127.
4. Delsol G, Falini B, Muller-Hermelink HK, Campo E, Jaffe Es, Gascoyne R, Stein H, Kinney MC. 2008. Anaplastic large cell lymphoma, ALK-positive. In: Swerdlow S, Campo E, Harris N, Jaffe E, Pileri S, Stein H, Thiele J, Vardiman J, editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th ed. Lyon: International Agency for Research on Cancer, p. 312-316.
5. Durkop H, Foss HD, Demel G, Klotzbach H, Hahn C, Stein H. 1999. Tumor necrosis factor receptor-associated factor 1 is overexpressed in Reed-Sternberg cells of Hodgkin's disease and Epstein-Barr virus-transformed lymphoid cells. Blood 93:617-623.
6. Feldman AL, Dogan A, Smith DI, Law ME, Ansell SM, Johnson SH, Porcher JC, Ozsan N, Wieben ED, Eckloff BW, Vasmatzis G. 2011. Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively-parallel genomic sequencing. Blood 117:915-919.
7. Gambacorti-Passerini C, Messa C, Pogliani EM. 2011. Crizotinib in anaplastic large-cell lymphoma. N Engl J Med 364:775-776.
8. Kurtin PJ, Hobday KS, Ziesmer S, Caron BL. 1999. Demonstration of distinct antigenic profiles of small B-cell lymphomas by paraffin section immunohistochemistry. Am J Clin Pathol 112:319-329.
9. Martelli MP, Sozzi G, Hernandez L, Pettirossi V, Navarro A, Conte D, Gasparini P, Perrone F, Modena P, Pastorino U, Carbone A, Fabbri A, Sidoni A, Nakamura S, Gambacorta M, Fernandez PL, Ramirez J, Chan JK, Grigioni WF, Campo E, Pileri SA, Falini B. 2009. EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues. Am J Pathol 174:661-670.
10. Mason DY, Harris NL, Delsol G, Stein H, Campo E, Kinney MC, Jaffe ES, Falini B. 2008. Anaplastic large cell lymphoma, ALK-negative. In: Swerdlow S, Campo E, Harris N, Jaffe E, Pileri S, Stein H, Thiele J, Vardiman J, editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th ed. Lyon: International Agency for Research on Cancer, p 317-319.
11. Mologni L. 2012. Inhibitors of the anaplastic lymphoma kinase. Expert Opin Investig Drugs 21:985-994.
12. Panagopoulos I, Nilsson T, Domanski HA, Isaksson M, Lindblom P, Mertens F, Mandahl N. 2006. Fusion of the SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor. Int J Cancer 118:1181-1186.
13. Rothe M, Wong SC, Henzel WJ, Goeddel DV. 1994. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78:681-692.
14. Savage KJ, Harris NL, Vose JM, Ullrich F, Jaffe ES, Connors JM, Rimsza L, Pileri SA, Chhanabhai M, Gascoyne RD, Armitage JO, Weisenburger DD. 2008. ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: Report from the International Peripheral T-Cell Lymphoma Project. Blood 111:5496-5504.
15. Stein H, Foss HD, Durkop H, Marafioti T, Delsol G, Pulford K, Pileri S, Falini B. 2000. CD30(+) anaplastic large cell lymphoma: A review of its histopathologic, genetic, and clinical features. Blood 96:3681-3695.
16. Trinei M, Lanfrancone L, Campo E, Pulford K, Mason DY, Pelicci PG, Falini B. 2000. A new variant anaplastic lymphoma kinase (ALK)-fusion protein (ATIC-ALK) in a case of ALK-positive anaplastic large cell lymphoma. Cancer Res 60:793-798.
17. Vasmatzis G, Johnson SH, Knudson RA, Ketterling RP, Braggio E, Fonseca R, Viswanatha DS, Law ME, Kip NS, Ozsan N, Grebe SK, Frederick LA, Eckloff BW, Thompson EA, Kadin ME, Milosevic D, Porcher JC, Asmann YW, Smith DI, Kovtun IV, Ansell SM, Dogan A, Feldman AL. 2012. Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas. Blood 120:2280-2289.
18. Vose J, Armitage J, Weisenburger D. 2008. International peripheral T-cell and natural killer/T-cell lymphoma study: Pathology findings and clinical outcomes. J Clin Oncol 26:4124-4130.